Enovis (ENOV) EPS (Weighted Average and Diluted) (2010 - 2026)
Enovis (ENOV) reported EPS (Weighted Average and Diluted) of -$0.15 for Q2 2026, up 84.69% year-over-year from -$0.08 in Q2 2025, and up 98.35% on a QoQ basis from -$9.08 in Q4 2025.
Enovis (ENOV) has 17 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.15 in Q2 2026.
- Quarterly EPS (Weighted Average and Diluted) rose 84.69% year-over-year to -$0.15 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$19.86 (down 35.84% YoY) and the FY2025 annual result came in at -$20.72, down 38.32% from the prior year.
- EPS (Weighted Average and Diluted) grew to -$0.15 in Q2 2026 per ENOV's latest filing, from -$9.08 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $1.41 in Q3 2022 and bottomed at -$12.72 in Q4 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.58 (2024), against an average of -$2.17.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) surged 269.88%; it then plunged 25540.0% in 2024.
- Tracing ENOV's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.71 in 2022, then surged by 107.04% to $0.05 in 2023, then tumbled by 25540.0% to -$12.72 in 2024, then increased by 28.62% to -$9.08 in 2025, then surged by 98.35% to -$0.15 in 2026.
- Per Business Quant, the three latest ENOV EPS (Weighted Average and Diluted) figures stand at -$0.15 (Q2 2026), -$9.08 (Q4 2025), and -$9.99 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | -0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -0.15 |
| Dec 31, 2025 | -9.08 |
| Oct 3, 2025 | -9.99 |
| Jul 4, 2025 | -0.64 |
| Apr 4, 2025 | -0.98 |
| Dec 31, 2024 | -12.72 |
| Sep 27, 2024 | -0.58 |
| Jun 28, 2024 | -0.34 |
| Mar 29, 2024 | -1.32 |
| Dec 31, 2023 | 0.05 |
| Sep 29, 2023 | -0.36 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -0.71 |
| Sep 30, 2022 | -1.22 |
| Jul 1, 2022 | 1.41 |
| Apr 1, 2022 | 0.28 |
| Dec 31, 2021 | -0.04 |
| Oct 1, 2021 | -0.26 |
| Jul 2, 2021 | -0.83 |
| Apr 2, 2021 | -0.69 |
| Dec 31, 2020 | 0.24 |
| Oct 2, 2020 | 0.12 |
| Jul 3, 2020 | -0.06 |
| Apr 3, 2020 | 0.03 |
| Dec 31, 2019 | -0.12 |
| Sep 27, 2019 | 0.02 |
| Jun 28, 2019 | 0.01 |
| Mar 29, 2019 | -0.39 |
| Dec 31, 2018 | 0.39 |
| Sep 28, 2018 | 0.14 |
| Jun 29, 2018 | 0.38 |
| Mar 30, 2018 | 0.20 |
| Dec 31, 2017 | 0.11 |
| Sep 29, 2017 | 0.37 |
| Jun 30, 2017 | 0.30 |
| Mar 31, 2017 | 0.29 |
| Dec 31, 2016 | 0.31 |
| Sep 30, 2016 | 0.23 |
| Jul 1, 2016 | 0.32 |
| Apr 1, 2016 | 0.19 |
| Dec 31, 2015 | 0.36 |
| Sep 25, 2015 | 0.15 |
| Jun 26, 2015 | 0.42 |
| Mar 27, 2015 | 0.42 |
| Dec 31, 2014 | 0.64 |
| Sep 26, 2014 | 0.59 |
| Jun 27, 2014 | 1.53 |
| Mar 28, 2014 | 0.22 |
| Dec 31, 2013 | 0.31 |
| Sep 27, 2013 | 0.48 |
| Jun 28, 2013 | 0.52 |
| Mar 29, 2013 | 0.21 |
| Dec 31, 2012 | 0.13 |
| Sep 28, 2012 | 0.04 |
| Jun 29, 2012 | 0.07 |
| Jul 1, 2011 | 0.23 |
| Jul 2, 2010 | 0.05 |